Chardan Capital Markets Downgrades The Medicines Company (MDCO) to Neutral on Valuation, Removes as Top Pick
Tweet Send to a Friend
Chardan Capital Markets analyst Gbola Amusa downgraded The Medicines Company (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
